Comparing Clariscan vs Dotarem
| Clariscan (gadoterate meglumine) | Dotarem (gadoterate meglumine) |
|
|---|
| Clariscan (gadoterate meglumine) | Dotarem (gadoterate meglumine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for CNS Magnetic Resonance Imaging. Clariscan may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for CNS Magnetic Resonance Imaging. Dotarem may also be used for purposes not listed in this medication guide. |
Related suggestions CNS Magnetic Resonance Imaging
|
|||||||||||||||
| More about Clariscan (gadoterate meglumine) | More about Dotarem (gadoterate meglumine) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Be the first to share your experience with this drug. |
Dotarem has an average rating of 2.9 out of 10 from a total of 8 ratings on Drugs.com. 13% of reviewers reported a positive effect, while 75% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Clariscan side effects |
View all Dotarem side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Lower cost generic approved | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Clariscan prices |
View all Dotarem prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other gadoterate meglumine brands include: Dotarem | Other gadoterate meglumine brands include: Clariscan | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
15.1 hours |
15.1 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
|
Category C
Risk cannot be ruled out
|
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 40 drugs are known to interact with Clariscan:
|
A total of 40 drugs are known to interact with Dotarem:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
November 01, 2019 |
March 20, 2013 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Magnevist
Magnevist (gadopentetate dimeglumine) is a contrast agent used to help diagnose certain disorders ...
Gadavist
Gadavist (gadobutrol) is a contrast agent used in MRI's to help diagnose certain disorders of the ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Dotarem
Dotarem (gadoterate meglumine) is a gadolinium-based contrast agent used in magnetic resonance ...
Omniscan
Omniscan is used for CNS Magnetic Resonance Imaging, vascular magnetic resonance imaging
Multihance
Multihance is used for CNS Magnetic Resonance Imaging, magnetic resonance angiography
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.